Home
About us
Editorial board
Ahead of print
Browse Articles
Search
Submit article
Instructions
Subscribe
Contacts
Login
Advanced Search
Users Online: 1352
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the left side.
All
|
Case Report
|
Case Reports
|
Editorial
|
Erratum
|
Letter To Editor
|
Letters to Editor
|
Mini Review
|
Notice of Retraction
|
Original Article
|
Original Articles
|
Review Article
|
Review Articles
|
Short Communication
|
Short Communications
|
Systematic Review
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Review Article:
Use of sedative drugs at reducing the side effects of voiding cystourethrography in children
Anahita Alizadeh, Maryam Naseri, Yalda Ravanshad, Shahabaddin Sorouri, Malihe Banihassan, Anoush Azarfar
J Res Med Sci
2017, 22:42 (15 March 2017)
DOI
:10.4103/1735-1995.202139
PMID
:28465701
Background:
Imaging of the kidneys and urinary tract has a significant and critical role for diagnosis of genitourinary system diseases. Although technological progress goes toward less invasive approaches, some of the current methods are still invasive and annoying. Voiding cystourethrography (VCUG) is the best and most accurate method for diagnosis and grading of vesicoureteral reflux. VCUG is a distressful procedure that gives serious anxiety and pain in a large proportion of children and fear for parents; therefore, using effective sedative drugs with the least side effects is necessary and should be considered.
Materials and Methods:
In this review article, importance and efficacy of different drugs before catheterization VCUG be compared in the base of literature survey on EMBASE, PubMed, and Cochrane source.
Results:
We found that the treatment should be based on nonpharmacological and pharmacological methods; nonpharmacological treatment includes the psychological preparation before procedures as a safety precaution with little or no risk modality, as well as reassuring support. The presence of parents during painful procedures cannot alleviate children distress. Pharmacological methods include oral midazolam (0.5 mg/kg) and intranasal use (0.2 mg/kg) that had been used 10 min before the procedure can effect on anterograde amnesia and sedation without considerable effect on accuracy and grade of reflux. Nitric oxide has a shorter recovery time versus midazolam but has a potential risk for deep sedation and may interfere with the child's voiding phase.
Conclusion:
In summary, oral midazolam of 0.5–0.6 mg/kg or 0.2 mg/kg intranasal is acceptable drug that can be used before VCUG.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Short Communication:
Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
Fereshte Ashtari, Ali Safaei, Vahid Shaygannejad, Mohammad Amin Najafi, Sahar Vesal
J Res Med Sci
2017, 22:41 (15 March 2017)
DOI
:10.4103/1735-1995.202142
PMID
:28465700
Background:
Neuromyelitis optica spectrum disease (NMOSD) is a severe autoimmune demyelinating disorder of the central nervous system that throughout epidemiological data, it has not been completely determined. The aim of this study was to assess characteristics of NMOSD patients in Isfahan as one of the most prevalent cities for multiple sclerosis in Iran.
Materials and Methods:
Forty-five patients diagnosed as neuromyelitis optica (NMO) disease through 5 years enrolled in this study. Demographics and characteristics of disease such as Expanded Disability Status Scale (EDSS) score, disease duration, clinical symptoms, laboratory data, and magnetic resonance imaging findings (including T1, T2, and flair protocols) were recorded. NMO-immunoglobulin G serology assay was done in all of the patients by ELISA test.
Results:
Female to male ratio was 5.4:1. The mean age of disease onset was 29.8 ± 11.2 years. NMO antibody was positive in 24.4% of patients. The presenting symptoms were optic neuritis (55.5%), transverse myelitis (40%), and brainstem symptoms (4.5%). The interval between the first and second attack was 19.28 ± 31.27 months (range: 1 month to 17 years). The mean EDSS score of the patients was 2.8 ± 2.25. Frequency of long-extending cervical plaque was higher among men than women (85.7% vs. 57.9%).
Conclusion:
Based on this study, the mean age of NMOSD onset among Isfahan population was considerably lower than other studies, and there was higher frequency of long-extending cervical lesion among male patients which needs more consideration in further studies.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (9) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Transcription factor 7-like 2 polymorphism and context-specific risk of metabolic syndrome, type 2 diabetes, and dyslipidemia
Abbasali Palizban, Mahnaz Rezaei, Hossein Khanahmad, Mohammad Fazilati
J Res Med Sci
2017, 22:40 (15 March 2017)
DOI
:10.4103/1735-1995.202141
PMID
:28465699
Background:
The transcription factor 7-like 2 gene (TCF7L2) is an element of the Wnt signaling pathway. There is lack of evidence if TCF7L2 has a functional role in lipid metabolism and regulation of the components constitutes the metabolic syndrome (MetSyn). The aims of this study were to evaluate whether the risk allele of TCF7L2 gene polymorphism is associated with dyslipidemia and MetSyn.
Materials and Methods:
The MetSyn subjects were participated only based on the National Cholesterol Education Program – Third Adult Treatment Panel criteria. In this case–control study, the DNA from MetSyn patients without (
n
= 90) and with type 2 diabetes (T2D) (
n
= 94) were genotyped.
Results:
The results show that the genotype-phenotype for CC, CT/TT of TCF7L2 gene polymorphism correlated with body mass index and waist circumference in MetSyn and MetSyn + T2D subjects (
r
= −0.949 and
r
= −0.963, respectively). The subjects that only possess MetSyn but are not diabetics show the 2 h postprandial glucose and fasting blood glucose, glycated hemoglobin significantly lower (
P
< 0.05) than those subjects have both abnormality. The level of triglyceride in CT/TT carriers in MetSyn was higher than CC carriers (
P
= 0.025). A comparison with the controls subjects, the frequencies of the T allele in the groups of MetSyn (46.66%) and MetSyn + T2D (47.34%) show significantly different (
P
< 0.05). The odds ratios for T allele in (MetSyn)/(normal), (MetSyn + T2D)/(normal), and in (MetSyn + T2D)/(MetSyn) were 3.59 (95% confidence interval [CI], 1.33–9.67,
P
= 0.0093), 3.76 (95% CI, 1.40–10.07,
P
= 0.0068), and 1.08 (95% CI: 0.55
–
2.11,
P
= 0.834), respectively.
Conclusion:
The results revealed the important insights essential for the role of TCF7L2 that the T allele of TCF7L2 plays a significant role in the susceptibility to dyslipidemia, MetSyn, and T2D.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (11) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Effects of atorvastatin on biomarkers of acute kidney injury in amikacin recipients: A pilot, randomized, placebo-controlled, clinical trial
Behrooz Heydari, Hossein Khalili, Mohammad-Taghi Beigmohammadi, Alireza Abdollahi, Iman Karimzadeh
J Res Med Sci
2017, 22:39 (15 March 2017)
DOI
:10.4103/1735-1995.202150
PMID
:28465698
Background:
The most common clinical indication of aminoglycosides (AG) is the treatment of serious Gram-negative infections. The aim of this study was to evaluate plausible effects of atorvastatin on the biomarkers of acute kidney injury (AKI) in patients receiving amikacin.
Materials and Methods:
In this double-blinded randomized clinical trial, fifty patients (25 in each group) receiving amikacin (15 mg/kg/day) were randomly assigned to either atorvastatin (40 mg/day) or placebo (40 mg/day) groups for 7 days. Blood urea nitrogen (BUN), serum creatinine (SCr), and urinary neutrophil gelatinase-associated lipocalin (NGAL) levels were measured at days 0, 1, and 7 of amikacin treatment.
Results:
During the study period, 4 (8%) patients including two patients in each atorvastatin and placebo group experienced AKI. Urine NGAL/urine Cr did not change significantly between and within placebo and atorvastatin groups during the study period. Similarly, the mean changes in SCr, BUN, and urine NGAL/urine Cr values did not differ significantly between and within patients with and without AKI.
Conclusion:
Our data suggested that the changing pattern of urine NGAL/urine Cr ratio did not differ significantly between the atorvastatin and placebo groups during the early phase of amikacin treatment.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
The effect of urethral catheterization on the level of prostate-specific antigen
Mohammad Hossein Izadpanahi, Hojatollah Salimi, Amir Javid, Salman Eslami
J Res Med Sci
2017, 22:38 (15 March 2017)
DOI
:10.4103/1735-1995.202145
PMID
:28465697
Background:
The normal prostate-specific antigen (PSA) level in patients with urethral catheterization is a controversy. We designed this study to investigate the effect of nontraumatic urethral catheterization without urinary retention on serum PSA.
Materials and Methods:
Seventy patients scheduled for urethral catheterization before elective surgeries were randomly selected and included in the study. They were categorized into two age groups: 40–60 years (Group A) and over 60 years (Group B). Total PSA, PSA density, and free/total PSA were assessed before and after catheterization.
Results:
The PSA levels showed no statistically significant rise after urethral catheterization. The average of PSA level was 1.01 and 1.6 in A and B Groups, respectively, and changed to 1.38 and 1.80 in A and B Groups 1 day after catheterization (
P
> 0.05). Free/total PSA was 28.75 and 26 in A and B Groups before catheterization and changed to 28.35 and 27.5 in A and B Groups after catheterization (
P
> 0.05).
Conclusion:
Nontraumatic urethral catheterization has very little effect on PSA level and in patients with urethral catheter routine evaluation of PSA rising should be considered.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Pimpinella anisum
L. fruit: Chemical composition and effect on rat model of nonalcoholic fatty liver disease
Ali Asadollahpoor, Mohammad Abdollahi, Roja Rahimi
J Res Med Sci
2017, 22:37 (15 March 2017)
DOI
:10.4103/1735-1995.202147
PMID
:28465696
Background:
Nonalcoholic fatty liver disease (NAFLD) includes a group of chronic liver disorders caused by irregular accumulation of fat in liver tissue. The current study aimed to evaluate chemical composition and the effect of fruit extract and essential oil of
Pimpinella anisum
in experimental model of NAFLD.
Materials and Methods:
Sixty rats were randomly divided into ten groups, six in each group. NAFLD was induced in rats using choline-deficient diet for 90 days, followed by 30 days of treatment with 25, 50, 100, and 200 mg/kg/day of hydroethanolic extract (AE) as well as 0.125, 0.25, and 0.5 mg/kg/day of essential oil (AO). Blood samples were collected in the final day, and lipid profile, aspartate aminotransferase (AST), alanine aminotransferase (ALT) as well as biomarkers of oxidative damage including myeloperoxidase, lipid peroxidation, total thiol molecules, and ferric-reducing ability of plasma were measured. Liver tissue sections of the sacrificed rats were also assessed histologically.
Results:
AE and AO significantly reversed increase in the plasma levels of total cholesterol, low-density lipoprotein, and triacylglycerol and decrease in high-density lipoprotein level in a dose-dependent manner (
P
< 0.05). Serum levels of AST and ALT were also significantly modified by treatment with AE and AO (
P
< 0.05). Biomarkers of oxidative stress were modulated by administration of AE and AO (
P
< 0.05). Histological assessments also confirmed the effectiveness of treatments by reduced macrovesicular steatohepatitis.
Conclusion:
It could be concluded that
P. anisum
fruit extract and essential oil have beneficial effects in the treatment of NAFLD. Further studies are necessary to confirm safety and efficacy of this medicinal plant in clinical setting.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (5) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Review Article:
Benefits, barriers, and limitations on the use of Hospital Incident Command System
Shahin Shooshtari, Shahram Tofighi, Shirin Abbasi
J Res Med Sci
2017, 22:36 (15 March 2017)
DOI
:10.4103/1735-1995.202146
PMID
:28465695
Hospital Incident Command System (HICS) has been established with the mission of prevention, response, and recovery in hazards. Regarding the key role of hospitals in medical management of events, the present study is aimed at investigating benefits, barriers, and limitations of applying HICS in hospital. Employing a review study, articles related to the aforementioned subject published from 1995 to 2016 were extracted from accredited websites and databases such as PubMed, Google Scholar, Elsevier, and SID by searching keywords such as HICS, benefits, barriers, and limitations. Then, those articles were summarized and reported. Using of HICS can cause creating preparedness in facing disasters, constructive management in strategies of controlling events, and disasters. Therefore, experiences indicate that there are some limitations in the system such as failure to assess the strength and severity of vulnerabilities of hospital, no observation of standards for disaster management in the design, constructing and equipping hospitals, and the absence of a model for evaluating the system. Accordingly, the conducted studies were investigated for probing the performance HICS. With regard to the role of health in disaster management, it requires advanced international methods in facing disasters. Using accurate models for assessing, the investigation of preparedness of hospitals in precrisis conditions based on components such as command, communications, security, safety, development of action plans, changes in staff's attitudes through effective operational training and exercises and creation of required maneuvers seems necessary.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (10) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients
Ozge Basaran, Nermin Uncu, Banu Acar Celikel, Fatma Aydın, Nilgun Cakar
J Res Med Sci
2017, 22:35 (15 March 2017)
DOI
:10.4103/1735-1995.202140
PMID
:28461821
Background:
Blood neutrophil to lymphocyte ratio (NLR) and mean platelet volume (MPV) both have been used as a simple marker of inflammation in many disorders. Here, we aimed to investigate the relationship between NLR, MPV, and familial Mediterranean fever (FMF).
Materials and Methods:
In this retrospective study, the files of FMF patients in pediatric rheumatology outpatient clinic were reviewed. There were 160 participants (68.4%) in the FMF patient group and 74 participants (31.6%) in the control group. Ninety of patients were in attack-free period, and 70 were in attack period.
Results:
The highest values of NLR were found in the patients at attack period. Patients in attack-free period and the participants in control group had similar levels of NLR (1.71 ± 0.83 and 1.91 ± 1.86 respectively) (
P
= 0.457), and they had lower ratios than the patients did at attack period (4.10 ± 3.11) (
P
< 0.001 for both). There was no significant difference between MPV values of attack patients (8.35 ± 4.91) and attack-free patients (8.43 ± 1.15) (
P
= 0.074). MPV values of attack patients and attack-free patients were significantly higher than control group (7.99 ± 0.81) (
P
< 0.001 for both).
Conclusion:
NLR ratio may indicate FMF attack period. Since there was no significant difference between attack-free patients and control groups, NLR ratio cannot be used as a subclinical inflammation marker. However, NLR could be a useful predictor of inflammation in FMF patients. On the other hand, since our attack and attack-free patients have similar MPV values and both had greater MPV values than control group, we suggest that MPV may be used to show subclinical inflammation.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (9) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Assessment of the role of plasma nitric oxide levels, T-786C genetic polymorphism, and gene expression levels of endothelial nitric oxide synthase in the development of coronary artery disease
Khalil Mahmoodi, Mohammad Soleiman Soltanpour, Koorosh Kamali
J Res Med Sci
2017, 22:34 (15 March 2017)
DOI
:10.4103/1735-1995.202144
PMID
:28461820
Background:
Reduced bioavailability of nitric oxide (NO) and the T-786C polymorphism of endothelial nitric oxide synthase (eNOS) gene have been reported as risk factors for the development of coronary artery disease (CAD) with conflicting results. We investigated the association of plasma NO levels, T-786C genetic polymorphism, and gene expression levels of eNOS with CAD risk in an Iranian subpopulation.
Materials and Methods:
Studied population included 100 patients with angiographically verified CAD and 100 ethnically matched controls. Analysis of T-786C genetic polymorphism and gene expression levels of eNOS was conducted by polymerase chain reaction (PCR) restriction fragment length polymorphism and real-time reverse transcription-PCR methods, respectively. Plasma levels of NO were measured using Griess method.
Results:
The CC genotype distribution (15% vs. 6%,
P
= 0.011) and minor C allele frequency (36.5% vs. 21.5%,
P
= 0.001) of eNOS T-786C polymorphism differed significantly between CAD patients and control. Furthermore, eNOS T-786C polymorphism was more common among smoker than nonsmoker CAD patients (27.7% vs. 7.8%,
P
= 0.044). The association of the eNOS T-786C polymorphism with the severity of CAD (number of diseased vessel) was significant (
P
< 0.05). The gene expression levels of eNOS were significantly lower in the heterozygote (0.49 ± 0.1,
P
= 0.023) and mutant homozygote (0.36 ± 0.09,
P
= 0.011) genotypes than that of wild-type genotype (
P
< 0.05). In addition, NO levels were significantly lower in CAD patients compared with control subjects (42.62 ± 12.26 vs. 55.48 ± 16.57,
P
= 0.002) and showed intergenotypic variation in the CAD patients.
Conclusion:
Our study indicated that reduced NO levels and eNOS T-786C genetic polymorphism are significant risk factors for the development and severity of CAD in the Iranian population.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (4) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Short Communication:
Report of
SLC3A1
/rBAT gene mutations in Iranian cystinuria patients: A direct sequencing study
Samaneh Markazi, Majid Kheirollahi, Abbas Doosti, Mehrdad Mohammadi
J Res Med Sci
2017, 22:33 (15 March 2017)
DOI
:10.4103/1735-1995.202149
PMID
:28461819
Background:
Considering a few studies on the genetic basis of the cystinuria in the Middle East and the population-specific distribution of mutations in the
SLC3A1
, we tried to find genetic variants in three exons (1, 3, and 8) of
SLC3A1
.
Materials and Methods:
In this study, exons 1, 3, and 8 of
SLC3A1
gene of 25 unrelated cystinuria patients searched for genetic variations by polymerase chain reaction and sequencing.
Results:
There were five different variations in our studied population. We found one mutation in the
SLC3A1
gene including missense variant M467K and identified three polymorphisms: nonsynonymous variant G38G, c. 610 + 169C>T and c. 610 + 147C>G within the
SLC3A1
gene, and one new variant.
Conclusion:
Our results confirm that cystinuria is a heterogeneous disorder at the molecular level and more studies are needed to identify the distribution and frequency of mutations causing cystinuria in the Iranian population.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Review Article:
The recurrence risk of genetic complex diseases
Mahdi Bijanzadeh
J Res Med Sci
2017, 22:32 (15 March 2017)
DOI
:10.4103/1735-1995.202143
PMID
:28461818
Complex inherited diseases affected by an interaction between collective effects of the genotype at one or multiple loci either to increase or to lower susceptibility to disease, combined with a variety of environmental exposures that may trigger, accelerate, exacerbate, or protect against the disease process. The new aspects of genetic techniques have been opened for diagnosis and analysis of inherited disorders. While appropriate Mendelian laws is applied to estimate the recurrence risk of single gene diseases, using empirical recurrence risks are the most important and available method to evaluate pedigree of complex (multifactorial), chromosomal, and unknown etiology disorders. Although, generally, empirical recurrent risks are not accurate, either because of the difference of gene frequencies and environmental factors among populations or heterogeneity of disease; using results of plenty family population studies, computerized estimating programs, genotyping technologies, and Genome-wide association studies (GWASs) of single nucleotide polymorphisms (SNPs), can make it possible nowadays to estimate these risks. The specific family situation and importance recurrence risks of some common complex genetic diseases will be presented in this review and some important multifactorial disorders' recurrence risks will be summarized to help genetic counselors for supporting families and representing better view of genetic disorders.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (6) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Letter to Editor:
Anti-ma2 receptor encephalitis mimicking Huntington chorea
Masoud Etemadifar, Mehri Salari, Hossein Badiee, Omid Mirmosayyeb
J Res Med Sci
2017, 22:31 (15 March 2017)
DOI
:10.4103/1735-1995.202148
PMID
:28461817
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (3) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Review Article:
A review of plant-based compounds and medicinal plants effective on atherosclerosis
Mehrnoosh Sedighi, Mahmoud Bahmani, Sedigheh Asgary, Fatemeh Beyranvand, Mahmoud Rafieian-Kopaei
J Res Med Sci
2017, 22:30 (15 March 2017)
DOI
:10.4103/1735-1995.202151
PMID
:28461816
Atherosclerosis is one of the most important cardiovascular diseases that involve vessels through the development of fatty streaks and plaques. Plant-based compounds can help treat or prevent atherosclerosis through affecting the involved factors. The main purpose of this review article is to investigate and introduce medicinal plants and their potential activities regarding antioxidant properties, effective on lipids level and development of plaque, atherosclerosis, and progression of atherosclerosis as well as the development of cardiovascular disease and ischemia. To search for the relevant articles indexed in Information Sciences Institute, PubMed, Scientific Information Database, IranMedex, and Scopus between 1980 and 2013, with further emphasis on those indexed from 2004 to 2015, we used these search terms: atherosclerosis, antioxidant, cholesterol, inflammation, and the medicinal plants below. Then, the articles with inclusion criteria were used in the final analysis of the findings. Plant-based active compounds, including phenols, flavonoids, and antioxidants, can be effective on atherosclerosis predisposing factors and hence in preventing this disease and associated harmful complications, especially through reducing cholesterol, preventing increase in free radicals, and ultimately decreasing vascular plaque and vascular resistance. Hence, medicinal plants can contribute to treating atherosclerosis and preventing its progression through reducing cholesterolemia, free radicals, inflammation, vascular resistance, and certain enzymes. They, alone or in combination with hypocholesterolemic drugs, can therefore be useful for patients with hyperlipidemia and its complications.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (25) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Surgical correction of upper lip deficit in patients with cleft lip using dermis fat graft
Hossein Abdali, Ali Akbar Ataee Kachuee, Rastin Mohammadi-Mofrad, Mohammad Ali Hoghoughi, Nazgol Esmalian-Afyouni
J Res Med Sci
2017, 22:29 (15 March 2017)
DOI
:10.4103/jrms.JRMS_994_15
PMID
:28461815
Background:
This study aimed to assess dermis fat graft (DFG) as a choice to correct the tissue deficit in the free border of the upper lip in cleft lip repair surgery.
Materials and Methods:
Thirty-five individuals who referred to Alzahra Hospital at 2013–2014, with lip deformity following the primary repair surgery of cleft lip underwent surgery by DFG technique. Outcomes were assessed 4 months after the surgery based on comparison of preoperative and postoperative photographs.
Results:
The results in 18 (51.42%) patients were excellent, 10 (28.57%) good, and 7 (20%) intermediate according to the satisfaction of patients and investigators in terms of filling of lip deficit and motion of the upper lip. Moreover, complications and pain were minimal after 4-month follow-up.
Conclusion:
This method introduces an admissible method with 80% good to excellent results based on satisfactory of patients and surgeon.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (4) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2023
May
[
5
]
April
[
23
]
March
[
6
]
February
[
6
]
January
[
5
]
2022
December
[
7
]
November
[
5
]
October
[
6
]
September
[
10
]
August
[
7
]
July
[
10
]
June
[
6
]
May
[
7
]
April
[
8
]
March
[
9
]
February
[
10
]
January
[
8
]
2021
December
[
13
]
November
[
16
]
October
[
16
]
September
[
19
]
August
[
17
]
July
[
9
]
June
[
8
]
May
[
8
]
March
[
7
]
February
[
9
]
January
[
10
]
2020
December
[
8
]
November
[
9
]
October
[
9
]
September
[
8
]
August
[
9
]
July
[
9
]
June
[
11
]
May
[
11
]
April
[
10
]
March
[
13
]
February
[
10
]
January
[
10
]
2019
December
[
10
]
November
[
7
]
October
[
9
]
September
[
8
]
August
[
9
]
July
[
12
]
June
[
8
]
May
[
10
]
April
[
11
]
March
[
8
]
February
[
9
]
January
[
9
]
2018
December
[
9
]
November
[
9
]
October
[
9
]
September
[
8
]
August
[
9
]
July
[
10
]
June
[
10
]
May
[
10
]
April
[
10
]
March
[
10
]
February
[
8
]
January
[
10
]
2017
December
[
10
]
November
[
9
]
October
[
8
]
September
[
10
]
August
[
11
]
July
[
9
]
June
[
11
]
May
[
14
]
April
[
14
]
March
[
14
]
February
[
14
]
January
[
14
]
2016
December
[
14
]
November
[
28
]
October
[
14
]
September
[
16
]
August
[
8
]
July
[
6
]
June
[
16
]
May
[
8
]
April
[
8
]
March
[
7
]
February
[
6
]
January
[
5
]
1900
January
[
1
]
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Journal of Research in Medical Sciences | Published by Wolters Kluwer -
Medknow
Online since 9
th
February, 2015